Validación de "Action Research Arm Test" (ARAT) en pacientes con extremidad superior parética post ataque cerebro vascular en Chile

Background: Stroke is one of the main causes of disability and death in the world. Sixty three percent of stroke survivors require rehabilitation which is a complex functional recovery multidisciplinary task. Aim: To determine the psychometric properties of the Action Research Arm Test (ARAT), that...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Doussoulin S,Arlette, Rivas S,Rodrigo, Campos S,Viviana
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2012
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872012000100008
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872012000100008
record_format dspace
spelling oai:scielo:S0034-988720120001000082012-04-12Validación de "Action Research Arm Test" (ARAT) en pacientes con extremidad superior parética post ataque cerebro vascular en ChileDoussoulin S,ArletteRivas S,RodrigoCampos S,Viviana Cerebrovascular accident Clinical trials Disability Evaluation Background: Stroke is one of the main causes of disability and death in the world. Sixty three percent of stroke survivors require rehabilitation which is a complex functional recovery multidisciplinary task. Aim: To determine the psychometric properties of the Action Research Arm Test (ARAT), that is used to assess the functional recovery of a paretic upper limb. Patients and Methods: Eighty stroke survivors were assessed at their homes as a baseline and two months later applying ARAT and Motor Activity Log (MAL-30) assessments. In the latter evaluation quality of life was assessed with SIS 3.0 score and the General Health Questionnaire (GHQ-30) was applied. Participants received no intervention in the lapse between the two assessments. Results: Cronbach a values for ARAT were 0.88 and 0.89 at baseline and two months assessments, respectively. Temporary stability had an r value of 0. 93 (p < 0.01). The convergent validity with quality of movement of MAL-30 was r = 0.58 and r = 0.51. The figures with quantity of movement were r = 0.55 and r = 0.57. The convergent validity with SIS 3.0 was r = 0.53 for the hand, r = 0.57 for participation and r = 0.48 for recovery. ARATscores correlated inversely and significantly with age and pain. There was no discriminant validity between ARAT and emotion, memory, communication and mobility of SIS 3.0, GHQ-30 and the socio-economic level. Conclusions: ARAT is a reliable and valid instrument for assessing the functional recovery of paretic upper limbs after a stroke.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.140 n.1 20122012-01-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872012000100008es10.4067/S0034-98872012000100008
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Cerebrovascular accident
Clinical trials
Disability Evaluation
spellingShingle Cerebrovascular accident
Clinical trials
Disability Evaluation
Doussoulin S,Arlette
Rivas S,Rodrigo
Campos S,Viviana
Validación de "Action Research Arm Test" (ARAT) en pacientes con extremidad superior parética post ataque cerebro vascular en Chile
description Background: Stroke is one of the main causes of disability and death in the world. Sixty three percent of stroke survivors require rehabilitation which is a complex functional recovery multidisciplinary task. Aim: To determine the psychometric properties of the Action Research Arm Test (ARAT), that is used to assess the functional recovery of a paretic upper limb. Patients and Methods: Eighty stroke survivors were assessed at their homes as a baseline and two months later applying ARAT and Motor Activity Log (MAL-30) assessments. In the latter evaluation quality of life was assessed with SIS 3.0 score and the General Health Questionnaire (GHQ-30) was applied. Participants received no intervention in the lapse between the two assessments. Results: Cronbach a values for ARAT were 0.88 and 0.89 at baseline and two months assessments, respectively. Temporary stability had an r value of 0. 93 (p < 0.01). The convergent validity with quality of movement of MAL-30 was r = 0.58 and r = 0.51. The figures with quantity of movement were r = 0.55 and r = 0.57. The convergent validity with SIS 3.0 was r = 0.53 for the hand, r = 0.57 for participation and r = 0.48 for recovery. ARATscores correlated inversely and significantly with age and pain. There was no discriminant validity between ARAT and emotion, memory, communication and mobility of SIS 3.0, GHQ-30 and the socio-economic level. Conclusions: ARAT is a reliable and valid instrument for assessing the functional recovery of paretic upper limbs after a stroke.
author Doussoulin S,Arlette
Rivas S,Rodrigo
Campos S,Viviana
author_facet Doussoulin S,Arlette
Rivas S,Rodrigo
Campos S,Viviana
author_sort Doussoulin S,Arlette
title Validación de "Action Research Arm Test" (ARAT) en pacientes con extremidad superior parética post ataque cerebro vascular en Chile
title_short Validación de "Action Research Arm Test" (ARAT) en pacientes con extremidad superior parética post ataque cerebro vascular en Chile
title_full Validación de "Action Research Arm Test" (ARAT) en pacientes con extremidad superior parética post ataque cerebro vascular en Chile
title_fullStr Validación de "Action Research Arm Test" (ARAT) en pacientes con extremidad superior parética post ataque cerebro vascular en Chile
title_full_unstemmed Validación de "Action Research Arm Test" (ARAT) en pacientes con extremidad superior parética post ataque cerebro vascular en Chile
title_sort validación de "action research arm test" (arat) en pacientes con extremidad superior parética post ataque cerebro vascular en chile
publisher Sociedad Médica de Santiago
publishDate 2012
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872012000100008
work_keys_str_mv AT doussoulinsarlette validaciondeactionresearcharmtestaratenpacientesconextremidadsuperiorpareticapostataquecerebrovascularenchile
AT rivassrodrigo validaciondeactionresearcharmtestaratenpacientesconextremidadsuperiorpareticapostataquecerebrovascularenchile
AT campossviviana validaciondeactionresearcharmtestaratenpacientesconextremidadsuperiorpareticapostataquecerebrovascularenchile
_version_ 1718436606549950464